cDC2 and plasmacytoid dendritic cells diminish from tissues of patients with non-Hodgkin orbital lymphoma and idiopathic orbital inflammation

Eur J Immunol. 2020 Apr;50(4):548-557. doi: 10.1002/eji.201948370. Epub 2020 Jan 16.

Abstract

Non-Hodgkin orbital lymphoma (NHOL) and idiopathic orbital inflammation (IOI) are common orbital conditions with largely unknown pathophysiology. To investigate the immune cell composition of these diseases, we performed standardized 29 parameter flow cytometry phenotyping in peripheral blood mononuclear cells of 18 NHOL patients, 21 IOI patients, and 41 unaffected controls. Automatic gating by FlowSOM revealed decreased abundance of meta-clusters containing dendritic cells in patients, which we confirmed by manual gating. A decreased percentage of (HLA-DR+ CD303+ CD123+ ) plasmacytoid dendritic cells (pDC) in the circulation of IOI patients and decreased (HLA-DR+ CD11c+ CD1c+ ) conventional dendritic cells (cDC) type-2 for IOI patients were replicated in an independent cohort of patients and controls. Meta-analysis of both cohorts demonstrated that pDCs are also decreased in blood of NHOL patients and highlighted that the decrease in blood cDC type-2 was specific for IOI patients compared to NHOL or controls. Deconvolution-based estimation of immune cells in transcriptomic data of 48 orbital biopsies revealed a decrease in the abundance of pDC and cDC populations within the orbital microenvironment of IOI patients. Collectively, these data suggest a previously underappreciated role for dendritic cells in orbital disorders.

Keywords: FlowSOM; cDC2; idiopathic orbital inflammation; non-Hodgkin orbital lymphoma; plasmacytoid dendritic cells.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Differentiation
  • Cohort Studies
  • Cytokines / metabolism
  • Dendritic Cells / immunology*
  • Dendritic Cells / pathology
  • Female
  • HLA-DR Antigens / metabolism
  • Humans
  • Inflammation / immunology*
  • Inflammation / pathology
  • Lymphoma, Non-Hodgkin / immunology*
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Middle Aged
  • Orbit / immunology*
  • Orbit / pathology
  • Orbital Neoplasms / immunology*
  • Orbital Neoplasms / pathology
  • Th2 Cells / immunology

Substances

  • Cytokines
  • HLA-DR Antigens